Paths to the patient: Business models for drug discovery and development

JLABS | Paths to the patient: Business models for drug discovery and development

Turning a drug discovery into patient impact means choosing the right development path and knowing when to pivot. But how do you choose the best route for your drug?

Join Johnson & Johnson’s upcoming program as they bring together experts who have successfully traveled these paths and are ready to share insights into various development routes. Topics include academic-industry partnerships, IP strategies, spin-off creation, funding, and more. Don’t miss your chance to gain clarity on the pros and cons of different paths for your scientific breakthrough. Secure your place today to join fellow forward-thinking innovators in Utrecht this 3 June.

Start-ups, early innovators and entrepreneurs are welcome to register here or through the button below! We also welcome stakeholders supporting these start-ups.

When: 3 June
Time: 13:00 til 18:00
Location: Beatrix Building Jaarbeurs, Utrecht